NERx BioSciences Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $250K
Latest Deal Amount
  • Investors
  • 5

NERx BioSciences General Information

Description

Developer of targeted therapeutics intended to treat cancer. The company's cancer drugs are made by utilizing novel biopharmaceutical compounds that target specific cellular processes to detect and eliminate cancer cells without affecting the growth and composition of other cells, enabling medical researchers to identify and evaluate preclinical anti-cancer targets and treat cancer faster, safer and in a cost-effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 212 West 10th Street
  • Suite A-480
  • Indianapolis, IN 46202
  • United States
+1 (317) 000-0000

NERx BioSciences Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NERx BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 30-Aug-2019 $250K 00.00 Completed Clinical Trials - General
7. Later Stage VC 11-Jan-2019 000 00.000 Completed Clinical Trials - General
6. Grant 01-Jan-2017 00000 00000 Completed Clinical Trials - General
5. Angel (individual) 17-Jul-2016 Cancelled Clinical Trials - General
4. Grant 01-Jan-2016 00.000 00000 Completed Clinical Trials - General
3. Seed Round 00000 00000 Completed Clinical Trials - General
2. Grant 25-Oct-2012 $10K $100K Completed Clinical Trials - General
1. Debt - General $100K $100K Completed Clinical Trials - General
To view NERx BioSciences’s complete valuation and funding history, request access »

NERx BioSciences Executive Team (3)

Name Title Board Seat Contact Info
Robert Feltgen Co-Founder, Chief Executive Officer & Board Member
John Turchi Ph.D Co-Founder, President, Board Member & Chief Scientific Officer
Nicholas Ball Chief Financial Officer, Vice President of Finance & Board Member
To view NERx BioSciences’s complete executive team members history, request access »

NERx BioSciences Board Members (3)

Name Representing Role Since
Nicholas Ball NERx BioSciences Chief Financial Officer, Vice President of Finance & Board Member 000 0000
Robert Feltgen NERx BioSciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Teri Willey IU Ventures Board Member 000 0000
To view NERx BioSciences’s complete board members history, request access »

NERx BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NERx BioSciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0
IU Ventures Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
BioCrossroads Venture Capital Minority 000 0000 000000 0
CTM Investments Other Minority 000 0000 000000 0
To view NERx BioSciences’s complete investors history, request access »